Sign up for free newsletter

 

Dollars

SPDR S&P Biotech ETF receives settlement payment

State Street Global Advisors’ SPDR S&P Biotech ETF has received a payment as an authorised claimant from a class action settlement related to Dendreon Corp.

The total amount payable to the fund is USD233,312.
 
When the fund calculates its net asset value (NAV) per share on 19 August it is estimated that the fund’s NAV will be impacted by USD0.0311 for each of the existing 7,500,000 shares.


Subscribe to free daily newsletter
latestjobs
Junior quantitative trader | hedge fund

Tue, 26 May 2015 00:00:00 GMT

VP Senior C++/Python Quantitative Developer

Tue, 26 May 2015 00:00:00 GMT

UI JavaScript Developer - FINTECH

Tue, 26 May 2015 00:00:00 GMT

specialreports